Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2014
11/20/2014US20140341851 Novel benzimidazole derivatives
11/20/2014US20140341850 Haloalkyl heteroaryl benzamide compounds
11/18/2014US8889875 Pyridyl derivatives as CFTR modulators
11/18/2014US8889871 Hepatitis C virus inhibitors
11/18/2014US8889868 CC-1065 analogs and their conjugates
11/18/2014US8889839 Pyridine-bis (oxazoline)(“pybox”) moiety as a chelator and sensitizer for lanthanide ion (Ln (III)) Luminescence
11/18/2014US8889730 Indole and indazole compounds that activate AMPK
11/18/2014US8889723 Aminoalkyloxazole and aminoalkylthiazolecarboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissues
11/18/2014US8889712 IAP antagonists
11/18/2014US8889710 Parasiticidal dihydroisoxazole compounds
11/18/2014US8889709 Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
11/18/2014US8889702 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
11/18/2014US8889700 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
11/18/2014US8889694 N-alkoxyamides of 6-(substituted phenyl)-4-aminopicolinates and 2-(substituted phenyl)-6-amino-4-pyrimidinecarboxylates and their use as selective herbicides for crops
11/18/2014US8889692 Pyrazinone derivatives, pharmaceutically acceptance salts thereof and their uses
11/18/2014US8889691 Indole compounds as an inhibitor of cellular necrosis
11/18/2014US8889683 Substituted quinoxalines as inhibitors of fatty acid binding protein
11/18/2014US8889682 Inhibitors of bruton'S tyrosine kinase
11/18/2014US8889674 Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism
11/18/2014US8889673 Triazolopyridine JAK inhibitor compounds and methods
11/18/2014US8889670 Heterocyclic compounds which modulate the CB2 receptor
11/18/2014US8889668 Oxadiazole diaryl compounds
11/18/2014US8889664 Phosphatidylinositol 3-kinase inhibitors and methods of their use
11/18/2014US8889267 Organic light emitting device
11/13/2014US20140336388 Nitrofurfuryl Substituted Phenyl Linked Piperidino-Oxadiazoline Conjugates As Anti-Tubercular Agents And Process For The Preparation Thereof
11/13/2014US20140336377 Arylamide derivatives as ttx-s blockers
11/13/2014US20140336376 Pharmaceutical composition for treating diabetes
11/13/2014US20140336374 Process and intermediates for the production of ccr2 antagonists
11/13/2014US20140336224 Mineralocorticoid receptor antagonists
11/13/2014US20140336221 Antibiotic and Anti-Parasitic Agents that Modulate Class II Fructose 1, 6-Bisphosphate Aldolase
11/13/2014US20140336208 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
11/13/2014US20140336200 Arylosulfonamides for the treatment of cns diseases
11/13/2014US20140336198 Amine Derivatives as Potassium Channel Blockers
11/13/2014US20140336195 Aryloxmethyl cyclopropane derivatives as pde10 inhibitors
11/13/2014US20140336191 Quinolinyloxyphenylsulfonamides
11/13/2014US20140336190 Benzimidazole derivatives as bromodomain inhibitors
11/13/2014US20140336182 Aurora Kinase Modulators and Method of Use
11/13/2014US20140336174 Glucosylceramide Synthase Inhibition For The Treatment Of Collapsing Glomerulopathy And Other Glomerular Disease
11/13/2014US20140336172 Novel 2H-Indazoles as EP2 Receptor Antagonists
11/13/2014US20140336158 Nk1 antagonists
11/11/2014US8884030 Inhibitors of Flaviviridae viruses
11/11/2014US8884029 Dye for photoelectric conversion device and photoelectric conversion device
11/11/2014US8884006 Small-molecule inhibitors of Rac1 in metastatic breast cancer
11/11/2014US8883837 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
11/11/2014US8883828 2-aminopyridine analogs as glucokinase activators
11/11/2014US8883827 Azole derivatives as WTN pathway inhibitors
11/11/2014US8883826 Alkynyl derivatives as modulators of metabotropic glutamate receptors
11/11/2014US8883818 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
11/11/2014US8883799 Tricyclic PI3K inhibitor compounds and methods of use
11/11/2014US8883794 Pharmaceutical composition
11/11/2014US8883789 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
11/11/2014US8883785 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/11/2014US8883779 Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them
11/11/2014US8883778 Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
11/11/2014US8883763 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same
11/06/2014US20140330010 Phenylpyrrole derivative
11/06/2014US20140330007 2,4-pyrimidinediamine compounds and their uses
11/06/2014US20140329989 Preparation of micafungin intermediates
11/06/2014US20140329871 Small molecule anti-fibrotic compounds and uses thereof
11/06/2014US20140329866 Omega-carboxyarl substituted diphenyl ureas as raf kinase inhibitors
11/06/2014US20140329825 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
11/06/2014US20140329822 N-piperidin-4-yl derivatives
11/06/2014US20140329821 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
11/06/2014US20140329816 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/06/2014US20140329806 Novel solid forms
11/06/2014US20140329797 Substituted oxadiazolyl pyridinones and oxadiazolyl pyridazinones as hif inhibitors
11/06/2014US20140329796 Heterocyclic amide derivative and pharmaceutical product containing same
11/06/2014US20140329795 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/06/2014US20140329794 Prmt5 inhibitors and uses thereof
11/06/2014US20140328805 Biheteroaryl compounds and uses thereof
11/04/2014US8877934 N-heteroaryl compounds
11/04/2014US8877924 Benzyl substituted triazine derivatives and their therapeutical applications
11/04/2014US8877923 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitors
11/04/2014US8877804 Sulfur derivatives as chemokine receptor modulators
11/04/2014US8877801 Compounds and compositions as selective estrogen receptor degraders
11/04/2014US8877797 Methods for treating Parkinson's disease using pro-neurogenic compounds
11/04/2014US8877783 Isoxazolo-pyridine derivatives
11/04/2014US8877782 Isoxazolo-pyridine derivatives
11/04/2014US8877780 5-substituted isoindoline compounds
11/04/2014US8877759 Aminopyrazines as ATR kinase inhibitors
11/04/2014US8877757 Pyrazine derivatives and use as PI3K inhibitors
11/04/2014US8877752 4(1H)-quinolones having antimalarial activity with reduced chemical resistance
11/04/2014US8877751 Benzothiazolone derivatives
11/04/2014US8877750 2-oxy-benzoxazinone derivatives for the treatment of obesity
11/04/2014US8877749 Spirocyclic compounds as modulators of chemokine receptor activity
11/04/2014US8877747 Indenone derivative and pharmaceutical composition comprising same
11/04/2014US8877745 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
11/04/2014US8877744 1,4-Oxazepines as BACE1 and/or BACE2 inhibitors
11/04/2014US8877707 Inhibitors of HCV NS5A
11/04/2014US8877315 Indolium compound and optical recording material containing the same
10/2014
10/30/2014US20140323722 Oxadiazole derivative having endothelial lipase inhibitory activity
10/30/2014US20140323524 Anti-Proliferative Compounds and Methods for Using the Same
10/30/2014US20140323499 Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x2/3 antagonists
10/30/2014US20140323486 Heterocyclic urea compounds
10/30/2014US20140323485 N-Substituted Heterocyclyl Carboxamides
10/30/2014US20140323484 Pharmaceutically Active Pyrazine Derivatives
10/30/2014US20140323469 1,4 oxazepines as bace1 and/or bace2 inhibitors
10/30/2014US20140323463 Pyrazinecarboxamide compound
10/30/2014US20140323458 Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
10/30/2014US20140323448 sGC STIMULATORS
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 647